TipRanks
Go Ultimate55% OFF

Cipher Pharmaceuticals (PHE) Revenue

Cipher Pharmaceuticals Revenue

Cipher Pharmaceuticals had a revenue of 11.76M in the quarter ending Jun 30, 2026, with -4.43%. This bring the company's revenue in the last twelve months to 49.29M, Decreased 3.19%. In the fiscal year ending Dec 31, 2025, Cipher Pharmaceuticals had annual revenue of 51.33M with 53.87% growth.

Revenue (ttm)
49.29M
Revenue Growth
-2.75%
P/S Ratio
4.13
Revenue/Employee
EUR 10,266,834
Employees
5
Market Cap
EUR 211.80M

Revenue Chart

Cipher Pharmaceuticals Revenue - Annual

010M20M30M40M50M60M40.32M22.75M22.45M21.61M21.94M20.68M21.16M33.36M51.33M201720182019202020212022202320242025
Revenue History
Download to Excel
DE:PHE revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 202551.33M17.97M53.87%
Dec 31, 202433.36M12.20M57.66%
Dec 31, 202321.16M487.00K2.36%
Dec 31, 202220.68M-1.27M-5.78%
Dec 31, 202121.94M336.00K1.56%
Dec 31, 202021.61M-844.00K-3.76%
Dec 31, 201922.45M-298.00K-1.31%
Dec 31, 201822.75M-17.57M-43.58%
Dec 31, 201740.32M――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
DE:PHE49.29M
TSE:GUD547.30M
TSE:MDP103.30M
TSE:RX55.67M
TSE:HLS55.89M
TSE:CRDL0.00